Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series C brings Israeli neurostim firm BrainsGate $27.5mm

Executive Summary

First-time investor Johnson & Johnson Development Corp. led the $27.5mm Series C financing in BrainsGate (electrical spheno-palatin ganglion stimulation). Fellow new backer Agate Medical Investments also participated ($5mm), along with returning shareholders including Elron Electronic Industries ($6.6mm, increasing its stake to 23.3%), Pitango Venture Capital, MB Venture Capital, and Alice Ventures. The company, which had a pre-money value of $50mm, will use the proceeds for a key study needed to support regulatory filing of its electrode implant for acute ischemic stroke.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
  • Medical Devices
    • Implantable Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies